AI-Powered Cancer Monitoring Test Launched Across Europe

C2i Genomics launches minimal residual disease test across Europe.

Related Keywords

New York ,United States ,Denmark ,United Kingdom ,Singapore ,China ,Switzerland ,France ,American ,Asaf Zviran ,Gustave Roussy ,American Association For Cancer Research ,European Union ,American Association ,Cancer Research ,New Orleans ,Illumina Novaseq ,Southeast Asia ,Twist Bioscience ,